# Novocol Pharmaceutical of Canada, Inc. – FDA Inspection, Jul 26, 2017

Source: https://www.keypedia.com/records/fda_inspections/novocol-pharmaceutical-of-canada-inc/da862aae-318c-4735-bb6c-6b113e69b6ce
Source feed: FDA_Inspections

> FDA inspection 1019963 of Novocol Pharmaceutical of Canada, Inc., July 26, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 314. Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1019963
- Company Name: Novocol Pharmaceutical of Canada, Inc.
- Inspection Date: 2017-07-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1243223 - 2024-05-03
- FDA Inspection 1117454 - 2020-01-30
- FDA Inspection 1098218 - 2019-06-21
- [FDA Inspection 1093310 - 2019-06-18](https://www.keypedia.com/records/fda_inspections/novocol-pharmaceutical-of-canada-inc/5a9546ca-45e2-4264-a4d2-5e3257507745)
- FDA Inspection 1072908 - 2018-11-02

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/anita-r-michael/b7699b1a-4157-477e-8226-2cfc906fc61d)

Company: https://www.keypedia.com/companies/novocol-pharmaceutical-of-canada-inc/28ac0d84-7b4b-4be0-96a8-9daeafbb5ac3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c